Linked Life Data

11665723

Source:http://linkedlifedata.com/resource/pubmed/id/11665723

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Suppl
pubmed:dateCreated
2001-10-22
pubmed:abstractText
Ciclopirox nail lacquer solution 8%, effective and safe for the treatment of dermatophyte onychomycosis of mild-to-moderate severity, covers a broad-spectrum of organisms and also may be effective in onychomycosis caused by Candida species and nondermatophyte molds. In addition, ciclopirox nail lacquer may be an important adjunct to oral antifungal therapy in certain presentations (eg, lateral onychomycosis, longitudinal spike, dermatophytoma, extensive onycholysis) that might respond poorly to oral antifungal therapy alone. Combination therapy with an oral antifungal agent may reduce the duration and cumulative dosage of oral therapy. In some cases, however, surgical therapies may be preferred or needed in addition to topical nail lacquer treatment. Ciclopirox nail lacquer also may be valuable in the treatment of early cases of reinfection and relapse. Treatment with ciclopirox nail lacquer for onychomycosis has a favorable risk-benefit ratio. Studies to determine the role of combination oral and topical nail lacquer therapy for the management of onychomycosis are needed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0011-4162
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13-6
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Ciclopirox nail lacquer: a brush with onychomycosis.
pubmed:affiliation
Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Review